A mitochondrial division inhibitor, Mdivi-1, inhibits mitochondrial fragmentation and attenuates kainic acid-induced hippocampal cell death
- Authors
- Kim, Hwajin; Lee, Jong Youl; Park, Keon Jae; Kim, Won-Ho; Roh, Gu Seob
- Issue Date
- Jun-2016
- Publisher
- BioMed Central
- Keywords
- Drp1; Mitochondrial fission; Neuroinflammation; Neuronal cell death
- Citation
- BMC Neuroscience, v.17, no.1
- Indexed
- SCIE
SCOPUS
- Journal Title
- BMC Neuroscience
- Volume
- 17
- Number
- 1
- URI
- https://scholarworks.gnu.ac.kr/handle/sw.gnu/15417
- DOI
- 10.1186/s12868-016-0270-y
- ISSN
- 1471-2202
- Abstract
- Background: Kainic acid (KA)-induced excitotoxicity promotes cytoplasmic calcium accumulation, oxidative stress, and apoptotic signaling, leading to hippocampal neuronal death. Mitochondria play a critical role in neuroinflammation and the oxidative stress response. Mitochondrial morphology is disrupted during KA-induced seizures; however, it is not clear whether mitochondrial fission or fusion factors are involved in KA-induced neuronal death. Results: We investigated the effect of Mdivi-1, a chemical inhibitor of the mitochondrial fission protein Drp1, on mitochondrial morphology and function in KA-injected mice. Mdivi-1 pretreatment significantly reduced seizure activity and increased survival rates of KA-treated mice. Mdivi-1 was protective against mitochondrial morphological disruption, and it reduced levels of phosphorylated Drp1 (Ser616) and Parkin recruitment to mitochondria. By contrast, levels of mitochondrial fusion factors did not change. Mdivi-1 also reduced KA-induced neuroinflammation and glial activation. Conclusions: We conclude that inhibition of mitochondrial fission attenuates Parkin-mediated mitochondrial degradation and protects from KA-induced hippocampal neuronal cell death.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medicine > Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.